Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
With the help of machine learning, researchers were able to train a computer to analyze breast cancer images and classify tumors accurately, according to a study published in NPJ Breast Cancer.
After receiving FDA clearance for AI software that can detect brain bleeds from CT images, MaxQ AI has announced a deal to integrate the software with medical imaging platforms.
In an interview with AI in Healthcare, JingJia Liu, chief executive officer at Wision AI, discussed the company's new machine-learning algorithm for polyp detection, what’s next and the impact of AI products in the medical industry.
A deep-learning system (DLS) designed by Google researchers outperformed several top general pathologists when grading prostate cancer on a standard grade, according to newly-published research.
An AI-based network outperformed several dermatologists while analyzing skin lesions for cancer, suggesting the technology could be a helpful tool for physicians regardless of their experience, according to a recent study.
HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.
Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.
Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.
